NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

北美的生物性骨材市場未來展望

North America Orthobiologics Market Outlook to 2025 - Bone Grafts and Substitutes, Bone Growth Stimulators, Cartilage Repair and Others

出版商 GlobalData 商品編碼 673477
出版日期 內容資訊 英文 164 Pages
訂單完成後即時交付
價格
北美的生物性骨材市場未來展望 North America Orthobiologics Market Outlook to 2025 - Bone Grafts and Substitutes, Bone Growth Stimulators, Cartilage Repair and Others
出版日期: 2021年02月10日內容資訊: 英文 164 Pages
簡介

本報告提供北美各國 (美國、加拿大、墨西哥) 生物性骨材的市場相關分析,地區整體的市場趨勢的變化和預測 (過去3年、今後8年份),各國詳細趨勢,主要企業、流通管道的市場佔有率,主要的開發中產品的目前臨床實驗情形,近來的資本交易、企業發展的動向,主要企業的簡介等相關調查。

第1章 目錄

第2章 簡介

  • 本報告概要
  • 生物性骨材市場區分
  • 分析對象定義

第3章 北美的生物性骨材市場

  • 市場收益額:各國 (以金額為準,總計11年份)
  • 市場收益額:各產品種類 (以金額為準,總計11年份)
  • 市場規模:各國 (以數量為準,總計11年份)
  • 市場規模:各產品種類 (以數量為準,總計11年份)
  • 市場收益額佔有率:各企業

第4章 加拿大的生物性骨材市場

  • 市場收益額 (以金額為準,總計11年份)
  • 市場規模 (以數量為準,總計11年份)
  • 平均價格 (總計11年份)
  • 市場收益額佔有率:各流通管道
  • 市場收益額佔有率:各企業

第5章 墨西哥的生物性骨材市場

第6章 美國的生物性骨材市場

第7章 主要企業分析:北美的生物性骨材市場

  • Medtronic Plc
  • Sanofi
  • DePuy Synthes Inc
  • Stryker Corp
  • Zimmer Biomet Holdings Inc
  • Anika Therapeutics Inc
  • Fidia farmaceutici SpA
  • ConMed Corporation
  • DJO Global Inc
  • LifeNet Health Inc
  • RTI Surgical Inc
  • 生化學工業
  • Bioventus LLC
  • Ferring Pharmaceuticals A/S
  • SeaSpine, Inc.

第8章 生物性骨材市場開發中產品

第9章 近幾年趨勢

  • 來自企業的發表 (企業傳訊)
  • 公佈財報
  • 政府、公益相關
  • 法規、規定相關
  • 其他主要動向
  • 產品新聞
  • 策略、產業計畫

第10章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECR1597DB

GlobalData's "North America Orthobiologics Market Outlook to 2025" is a comprehensive databook report, covering key market data on the North America Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Bone Grafts and Substitutes, Bone Growth Stimulators, Cartilage Repair, Soft Tissue Biologics and Viscosupplementation.

The North America Orthobiologics Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2019 company share and distribution share data for Orthobiologics Market.
  • Global corporate-level profiles of key companies operating within the North America Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Orthobiologics is segmented as follows -

  • Bone Grafts and Substitutes
  • Bone Growth Stimulators
  • Cartilage Repair
  • Soft Tissue Biologics
  • Viscosupplementation

Reasons to Buy

The North America Orthobiologics Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Orthobiologics Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Orthobiologics Market, North America

  • 3.1 Orthobiologics Market, North America, Revenue ($m), 2015-2025
  • 3.2 Orthobiologics Market, North America, Revenue ($m), 2015-2025
  • 3.3 Orthobiologics Market, North America, Volume (Units), 2015-2025
  • 3.4 Orthobiologics Market, North America, Volume (Units), 2015-2025
  • 3.5 Orthobiologics Market, North America, Company Share by Revenue ($m), 2019

4 Orthobiologics Market, Canada

  • 4.1 Orthobiologics Market, Canada, Revenue ($m), 2015-2025
    • 4.1.1 Bone Grafts and Substitutes Market, Canada, Revenue ($m), by Segment, 2015-2025
    • 4.1.2 Bone Growth Stimulators Market, Canada, Revenue ($m), by Segment, 2015-2025
    • 4.1.3 Cartilage Repair Market, Canada, Revenue ($m), by Segment, 2015-2025
    • 4.1.4 Soft Tissue Biologics Market, Canada, Revenue ($m), by Segment, 2015-2025
    • 4.1.5 Viscosupplementation Market, Canada, Revenue ($m), by Segment, 2015-2025
  • 4.2 Orthobiologics Market, Canada, Volume (Units), 2015-2025
    • 4.2.1 Bone Grafts and Substitutes Market, Canada, Volume (Units), by Segment, 2015-2025
    • 4.2.2 Bone Growth Stimulators Market, Canada, Volume (Units), by Segment, 2015-2025
    • 4.2.3 Cartilage Repair Market, Canada, Volume (Units), by Segment, 2015-2025
    • 4.2.4 Soft Tissue Biologics Market, Canada, Volume (Units), by Segment, 2015-2025
    • 4.2.5 Viscosupplementation Market, Canada, Volume (Units), by Segment, 2015-2025
  • 4.3 Orthobiologics Market, Canada, Average Price ($), 2015-2025
  • 4.4 Orthobiologics Market, Canada, Distribution Share by Revenue ($m), 2019
  • 4.5 Orthobiologics Market, Canada, Company Share by Revenue ($m), 2019

5 Orthobiologics Market, Mexico

  • 5.1 Orthobiologics Market, Mexico, Revenue ($m), 2015-2025
    • 5.1.1 Bone Grafts and Substitutes Market, Mexico, Revenue ($m), by Segment, 2015-2025
    • 5.1.2 Bone Growth Stimulators Market, Mexico, Revenue ($m), by Segment, 2015-2025
    • 5.1.3 Cartilage Repair Market, Mexico, Revenue ($m), by Segment, 2015-2025
    • 5.1.4 Soft Tissue Biologics Market, Mexico, Revenue ($m), by Segment, 2015-2025
    • 5.1.5 Viscosupplementation Market, Mexico, Revenue ($m), by Segment, 2015-2025
  • 5.2 Orthobiologics Market, Mexico, Volume (Units), 2015-2025
    • 5.2.1 Bone Grafts and Substitutes Market, Mexico, Volume (Units), by Segment, 2015-2025
    • 5.2.2 Bone Growth Stimulators Market, Mexico, Volume (Units), by Segment, 2015-2025
    • 5.2.3 Cartilage Repair Market, Mexico, Volume (Units), by Segment, 2015-2025
    • 5.2.4 Soft Tissue Biologics Market, Mexico, Volume (Units), by Segment, 2015-2025
    • 5.2.5 Viscosupplementation Market, Mexico, Volume (Units), by Segment, 2015-2025
  • 5.3 Orthobiologics Market, Mexico, Average Price ($), 2015-2025
  • 5.4 Orthobiologics Market, Mexico, Distribution Share by Revenue ($m), 2019
  • 5.5 Orthobiologics Market, Mexico, Company Share by Revenue ($m), 2019

6 Orthobiologics Market, United States

  • 6.1 Orthobiologics Market, United States, Revenue ($m), 2015-2025
    • 6.1.1 Bone Grafts and Substitutes Market, United States, Revenue ($m), by Segment, 2015-2025
    • 6.1.2 Bone Growth Stimulators Market, United States, Revenue ($m), by Segment, 2015-2025
    • 6.1.3 Cartilage Repair Market, United States, Revenue ($m), by Segment, 2015-2025
    • 6.1.4 Soft Tissue Biologics Market, United States, Revenue ($m), by Segment, 2015-2025
    • 6.1.5 Viscosupplementation Market, United States, Revenue ($m), by Segment, 2015-2025
  • 6.2 Orthobiologics Market, United States, Volume (Units), 2015-2025
    • 6.2.1 Bone Grafts and Substitutes Market, United States, Volume (Units), by Segment, 2015-2025
    • 6.2.2 Bone Growth Stimulators Market, United States, Volume (Units), by Segment, 2015-2025
    • 6.2.3 Cartilage Repair Market, United States, Volume (Units), by Segment, 2015-2025
    • 6.2.4 Soft Tissue Biologics Market, United States, Volume (Units), by Segment, 2015-2025
    • 6.2.5 Viscosupplementation Market, United States, Volume (Units), by Segment, 2015-2025
  • 6.3 Orthobiologics Market, United States, Average Price ($) , 2015-2025
  • 6.4 Orthobiologics Market, United States, Distribution Share by Revenue ($m), 2019
  • 6.5 Orthobiologics Market, United States, Company Share by Revenue ($m), 2019

7 Overview of Key Companies in North America Orthobiologics Market

  • 7.1 DePuy Synthes Inc
    • 7.1.1 Company Overview
  • 7.2 Stryker Corp
    • 7.2.1 Company Overview
  • 7.3 Smith & Nephew Plc
    • 7.3.1 Company Overview
  • 7.4 Medtronic Plc
    • 7.4.1 Company Overview
  • 7.5 Zimmer Biomet Holdings Inc
    • 7.5.1 Company Overview
  • 7.6 B. Braun Melsungen AG
    • 7.6.1 Company Overview
  • 7.7 Sanofi
    • 7.7.1 Company Overview
  • 7.8 Bioventus LLC
    • 7.8.1 Company Overview
  • 7.9 ConMed Corp
    • 7.9.1 Company Overview
  • 7.10 Ferring Pharmaceuticals AS
    • 7.10.1 Company Overview
  • 7.11 Arthrex Inc
    • 7.11.1 Company Overview
  • 7.12 Seikagaku Corp
    • 7.12.1 Company Overview
  • 7.13 Fidia farmaceutici SpA
    • 7.13.1 Company Overview
  • 7.14 SeaSpine, Inc.
    • 7.14.1 Company Overview
  • 7.15 Anika Therapeutics Inc
    • 7.15.1 Company Overview
  • 7.16 Orthofix Holdings Inc
    • 7.16.1 Company Overview

8 Orthobiologics Market Pipeline Products

9 Recent Developments

  • 9.1 Corporate Communications
    • 9.1.1 Jan 13, 2021: MTF Biologics awards over $1 Million in 2020 Extramural Research Grants and announces timeline for 2021 applications
    • 9.1.2 Mar 03, 2020: Ocular Therapeutix Provides update on interim data from the OTX-TKI Phase 1 clinical trial at the Cowen 40th Annual Health Care Conference
    • 9.1.3 Feb 14, 2020: CollPlant Biotechnologies raising $4.45 million in U.S. Private Placement
  • 9.2 Financial Announcements
    • 9.2.1 Mar 12, 2020: Lineage Cell Therapeutics reports fourth quarter and full year 2019 financial results and provides business update
    • 9.2.2 Feb 20, 2020: LX Analyzer successfully detects Coronavirus RNA
    • 9.2.3 Feb 19, 2020: Integra LifeSciences reports fourth quarter and full-year 2019 financial results and provides 2020 financial guidance
    • 9.2.4 Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results
    • 9.2.5 Jan 29, 2020: Current Health collaborates with Mass General Hospital to reduce maternal mortality rates in Sub-Saharan Africa
    • 9.2.6 Jan 28, 2020: Beckman Coulter's Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance
    • 9.2.7 Jan 24, 2020: The first patient included in Australia in Isofol's phase 3 AGENT study
  • 9.3 Legal And Regulatory
    • 9.3.1 Apr 06, 2020: MiMedx Group agrees to pay $6.5 million to resolve false claims act allegations of false commercial pricing disclosures
  • 9.4 Other Significant Developments
    • 9.4.1 Jul 28, 2020: Impressio and MedShape awarded competitive grant from the National Science Foundation to develop joint replacement device
    • 9.4.2 Jul 07, 2020: New collagen supply agreement with NovaBone Products
    • 9.4.3 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education
    • 9.4.4 May 28, 2020: Conformis announces settlement of patent dispute
    • 9.4.5 Apr 08, 2020: Anika takes actions to strengthen liquidity in light of covid-19
    • 9.4.6 Mar 04, 2020: CytoDyn treats first patient with Leronlimab in Phase 2 trial for GvHD under modified trial protocol
    • 9.4.7 Feb 12, 2020: Regenexx, first to use stem cells in orthopedic therapy, marks 15th anniversary
  • 9.5 Product News
    • 9.5.1 Nov 04, 2020: WFIRM scientists create hybrid tissue construct for cartilage regeneration
  • 9.6 Strategy And Business Planning
    • 9.6.1 Jun 26, 2020: Valet Health & DataBiologics combined solution support of data-driven physicians offering orthobiologics treatments
    • 9.6.2 Feb 20, 2020: Galderma announces New England Journal of Medicine publication from phase 2 study of investigational therapy Nemolizumab in patients with moderate to severe Prurigo Nodularis
    • 9.6.3 Feb 18, 2020: Georgia Bone & Joint Partners With AMP Recover To Service Self-Funded Employer Market

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Coverage
    • 10.1.2 Secondary Research
    • 10.1.3 Primary Research
    • 10.1.4 Market Modeling and Forecasting
    • 10.1.5 Company Share Analysis
    • 10.1.6 Distribution Share Analysis
    • 10.1.7 Benchmarking
  • 10.2 GlobalData Consulting
  • 10.3 Contact Us
  • 10.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Orthobiologics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025
  • Table 2: Orthobiologics Market, North America, Revenue ($m), Historic, USD Constant, 2015-2020
  • Table 3: Orthobiologics Market, No

List of Figures

List of Figures

  • Figure 1: Orthobiologics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025
  • Figure 2: Orthobiologics Market, North America, Revenue ($m), Historic, USD Constant, 2015-2025
  • Figure 3: Orthobiologics Market, North America, Volume (Units), 2015-2025
  • Figure 4: Orthobiologics Market, North America, Volume (Units), 2015-2025
  • Figure 5: Orthobiologics Market, North America, Company Share (%) 2019
  • Figure 6: Orthobiologics Market, Canada, Revenue ($m), USD Constant, 2015-2025
  • Figure 7: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, 2015-2025
  • Figure 8: Bone Growth Stimulators Market, Canada, Revenue ($m), USD Constant, 2015-2025
  • Figure 9: Cartilage Repair Market, Canada, Revenue ($m), USD Constant, 2015-2025
  • Figure 10: Soft Tissue Biologics Market, Canada, Revenue ($m), USD Constant, 2015-2025
  • Figure 11: Viscosupplementation Market, Canada, Revenue ($m), USD Constant, 2015-2025
  • Figure 12: Orthobiologics Market, Canada, Volume (Units), 2015-2025
  • Figure 13: Bone Grafts and Substitutes Market, Canada, Volume (Units), 2015-2025
  • Figure 14: Bone Growth Stimulators Market, Canada, Volume (Units), 2015-2025
  • Figure 15: Cartilage Repair Market, Canada, Volume (Units), 2015-2025
  • Figure 16: Soft Tissue Biologics Market, Canada, Volume (Units), 2015-2025
  • Figure 17: Viscosupplementation Market, Canada, Volume (Units), 2015-2025
  • Figure 18: Orthobiologics Market, Canada, Company Share (%) 2019
  • Figure 19: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, 2015-2025
  • Figure 20: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, 2015-2025
  • Figure 21: Bone Growth Stimulators Market, Mexico, Revenue ($m), USD Constant, 2015-2025
  • Figure 22: Cartilage Repair Market, Mexico, Revenue ($m), USD Constant, 2015-2025
  • Figure 23: Soft Tissue Biologics Market, Mexico, Revenue ($m), USD Constant, 2015-2025
  • Figure 24: Viscosupplementation Market, Mexico, Revenue ($m), USD Constant, 2015-2025
  • Figure 25: Orthobiologics Market, Mexico, Volume (Units), 2015-2025
  • Figure 26: Bone Grafts and Substitutes Market, Mexico, Volume (Units), 2015-2025
  • Figure 27: Bone Growth Stimulators Market, Mexico, Volume (Units), 2015-2025
  • Figure 28: Cartilage Repair Market, Mexico, Volume (Units), 2015-2025
  • Figure 29: Soft Tissue Biologics Market, Mexico, Volume (Units), 2015-2025
  • Figure 30: Viscosupplementation Market, Mexico, Volume (Units), 2015-2025
  • Figure 31: Orthobiologics Market, Mexico, Company Share (%) 2019
  • Figure 32: Orthobiologics Market, United States, Revenue ($m), USD Constant, 2015-2025
  • Figure 33: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2025
  • Figure 34: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, 2015-2025
  • Figure 35: Cartilage Repair Market, United States, Revenue ($m), USD Constant, 2015-2025
  • Figure 36: Soft Tissue Biologics Market, United States, Revenue ($m), USD Constant, 2015-2025
  • Figure 37: Viscosupplementation Market, United States, Revenue ($m), USD Constant, 2015-2025
  • Figure 38: Orthobiologics Market, United States, Volume (Units), 2015-2025
  • Figure 39: Bone Grafts and Substitutes Market, United States, Volume (Units), 2015-2025
  • Figure 40: Bone Growth Stimulators Market, United States, Volume (Units), 2015-2025
  • Figure 41: Cartilage Repair Market, United States, Volume (Units), 2015-2025
  • Figure 42: Soft Tissue Biologics Market, United States, Volume (Units), 2015-2025
  • Figure 43: Viscosupplementation Market, United States, Volume (Units), 2015-2025
  • Figure 44: Orthobiologics Market, United States, Company Share (%) 2019